Medicine guide
Welireg 40 mg
As listed in the register: Welireg 40 mg, Filmtabletten
40 mg ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Belzutifanum
- Made by
- MSD Merck Sharp & Dohme AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Von-Hippel-Lindau (VHL) - Krankheit, Fortgeschrittenes Nierenzellkarzinom (RCC)
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | MSD Merck Sharp & Dohme AG |
|---|---|
| Active substance | Belzutifanum |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 40 mg |
| Classification | L01XX74 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Welireg 40 mg, Filmtabletten |
| Packs | 90 Tablette(n) · 90 Tablette(n) |
| Zulassungsnummer | 68531 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.